4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0001209191-05-011657
Options or other derivatives
- CEO and CFO acquired 1,450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MANDELL HENRY R CEO and CFO | 2002-06-14 | Grant or award · Employee Stock Option | +500,000 | 600,000 | D | ||
| MANDELL HENRY R CEO and CFO | 2003-06-14 | Grant or award · Director Stock Option | +50,000 | 650,000 | D | ||
| MANDELL HENRY R CEO and CFO | 2003-11-12 | Grant or award · Director Stock Option | +100,000 | 750,000 | D | ||
| MANDELL HENRY R CEO and CFO | 2003-11-12 | Grant or award · Employee Stock Option | +250,000 | 1,000,000 | D | ||
| MANDELL HENRY R CEO and CFO | 2004-06-14 | Grant or award · Director Stock Option | +50,000 | 1,050,000 | D | ||
| MANDELL HENRY R CEO and CFO | 2005-02-21 | Grant or award · Employee Stock Option | +500,000 | 1,550,000 | D | ||
Loading xslF345X02/bcc06151_bcc1hrm.xml…